← Back to home

CHRONIC HEART FAILURE WITH REDUCED AND MILDLY REDUCED EJECTION FRACTION (HFREF AND HFMREF)

Clinical trials for CHRONIC HEART FAILURE WITH REDUCED AND MILDLY REDUCED EJECTION FRACTION (HFREF AND HFMREF) explained in plain language.

Never miss a new study

Get alerted when new CHRONIC HEART FAILURE WITH REDUCED AND MILDLY REDUCED EJECTION FRACTION (HFREF AND HFMREF) trials appear

Sign up with your email to follow new studies for CHRONIC HEART FAILURE WITH REDUCED AND MILDLY REDUCED EJECTION FRACTION (HFREF AND HFMREF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Heart failure drug puzzle: study aims to untangle polypharmacy risks

Knowledge-focused Ongoing

This study tracks 130 people with chronic heart failure to understand how taking multiple medications (polypharmacy) affects their safety, adherence, and health outcomes. Researchers will look for patterns of over- or under-prescribing and factors linked to low medication adheren…

Matched conditions: CHRONIC HEART FAILURE WITH REDUCED AND MILDLY REDUCED EJECTION FRACTION (HFREF AND HFMREF)

Sponsor: National Medical Research Center for Therapy and Preventive Medicine • Aim: Knowledge-focused

Last updated Jun 27, 2026 14:00 UTC

CHRONIC HEART FAILURE WITH REDUCED AND MILDLY REDUCED EJECTION FRACTION (HFREF AND HFMREF)

Get alerted when new CHRONIC HEART FAILURE WITH REDUCED AND MILDLY REDUCED EJECTION FRACTION (HFREF AND HFMREF) trials appear

Heart failure drug puzzle: study aims to untangle polypharmacy risks